| 0 |
BUTTOCK CRUSHING |
4 |
0.3077 |
| 1 |
BORDETELLA TEST POSITIVE |
2 |
0.1250 |
| 2 |
ANIRIDIA |
1 |
0.0833 |
| 3 |
FUNGAL TEST |
1 |
0.0769 |
| 4 |
BLOOD CARBON MONOXIDE DECREASED |
1 |
0.0667 |
| 5 |
LARYNGOSCOPY |
1 |
0.0476 |
| 6 |
NON-FUNCTIONAL KIDNEY |
1 |
0.0455 |
| 7 |
COMPENSATORY SWEATING |
1 |
0.0357 |
| 8 |
HYPER IGE SYNDROME |
4 |
0.0351 |
| 9 |
STAPHYLOCOCCAL SCALDED SKIN SYNDROME |
7 |
0.0311 |
| 10 |
COLD AGGLUTININS |
1 |
0.0303 |
| 11 |
CILIARY MUSCLE SPASM |
1 |
0.0294 |
| 12 |
HOLMES-ADIE PUPIL |
1 |
0.0263 |
| 13 |
TOTAL LUNG CAPACITY INCREASED |
7 |
0.0257 |
| 14 |
MUCOPOLYSACCHARIDOSIS II |
1 |
0.0213 |
| 15 |
BLOOD KETONE BODY DECREASED |
1 |
0.0213 |
| 16 |
MYDRIASIS |
273 |
0.0213 |
| 17 |
ANISOCORIA |
7 |
0.0185 |
| 18 |
SALIVARY HYPOSECRETION |
3 |
0.0185 |
| 19 |
HYPOHIDROSIS |
9 |
0.0179 |
| 20 |
COMA SCALE |
1 |
0.0164 |
| 21 |
ANHIDROSIS |
6 |
0.0147 |
| 22 |
EXPOSURE VIA EYE CONTACT |
6 |
0.0143 |
| 23 |
SCINTILLATING SCOTOMA |
3 |
0.0136 |
| 24 |
ANTICHOLINERGIC EFFECT |
1 |
0.0133 |
| 25 |
BARBITURATES POSITIVE |
1 |
0.0125 |
| 26 |
BLADDER STENOSIS |
1 |
0.0122 |
| 27 |
DRUG METABOLITE LEVEL HIGH |
1 |
0.0119 |
| 28 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
6 |
0.0115 |
| 29 |
URINARY HESITATION |
26 |
0.0109 |
| 30 |
APTYALISM |
9 |
0.0105 |
| 31 |
VULVOVAGINAL CANDIDIASIS |
14 |
0.0103 |
| 32 |
NEGATIVE PRESSURE PULMONARY OEDEMA |
1 |
0.0102 |
| 33 |
ATRIOVENTRICULAR DISSOCIATION |
2 |
0.0093 |
| 34 |
BODY MASS INDEX ABNORMAL |
2 |
0.0082 |
| 35 |
ADMINISTRATION SITE DISCOLOURATION |
1 |
0.0080 |
| 36 |
PROLONGED EXPIRATION |
2 |
0.0076 |
| 37 |
CONJUNCTIVAL IRRITATION |
1 |
0.0074 |
| 38 |
ADMINISTRATION SITE IRRITATION |
1 |
0.0071 |
| 39 |
CYSTIC LUNG DISEASE |
1 |
0.0070 |
| 40 |
APPLICATION SITE ODOUR |
1 |
0.0069 |
| 41 |
PEAK EXPIRATORY FLOW RATE DECREASED |
3 |
0.0068 |
| 42 |
PNEUMOCOCCAL INFECTION |
4 |
0.0068 |
| 43 |
BONE LESION EXCISION |
1 |
0.0066 |
| 44 |
CORNEA VERTICILLATA |
2 |
0.0066 |
| 45 |
BLOOD CREATININE |
1 |
0.0065 |
| 46 |
ABDOMINAL WALL WOUND |
1 |
0.0065 |
| 47 |
FEEDING TUBE COMPLICATION |
2 |
0.0064 |
| 48 |
ATTENTION-SEEKING BEHAVIOUR |
1 |
0.0064 |
| 49 |
PUPILS UNEQUAL |
7 |
0.0061 |
| 50 |
DYSDIADOCHOKINESIS |
1 |
0.0058 |
| 51 |
BLOOD LACTIC ACID DECREASED |
1 |
0.0058 |
| 52 |
PSEUDOMONAL SEPSIS |
10 |
0.0057 |
| 53 |
GENITOURINARY SYMPTOM |
1 |
0.0055 |
| 54 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
5 |
0.0054 |
| 55 |
EOSINOPHILIC BRONCHITIS |
1 |
0.0050 |
| 56 |
PULMONARY CALCIFICATION |
2 |
0.0048 |
| 57 |
KUSSMAUL RESPIRATION |
1 |
0.0048 |
| 58 |
STOMA SITE HYPERGRANULATION |
3 |
0.0048 |
| 59 |
NEUROMUSCULAR BLOCKADE |
1 |
0.0045 |
| 60 |
NASAL DRYNESS |
28 |
0.0045 |
| 61 |
ANTICHOLINERGIC SYNDROME |
7 |
0.0044 |
| 62 |
BRONCHIAL WALL THICKENING |
3 |
0.0042 |
| 63 |
DIABETIC VASCULAR DISORDER |
1 |
0.0040 |
| 64 |
DRY THROAT |
41 |
0.0040 |
| 65 |
INDIFFERENCE |
3 |
0.0040 |
| 66 |
REDUCED FACIAL EXPRESSION |
4 |
0.0039 |
| 67 |
ANTIPSYCHOTIC DRUG LEVEL DECREASED |
2 |
0.0038 |
| 68 |
FAECAL VOMITING |
2 |
0.0038 |
| 69 |
HEPATITIS B SURFACE ANTIGEN POSITIVE |
1 |
0.0036 |
| 70 |
APPENDICITIS PERFORATED |
9 |
0.0035 |
| 71 |
NON-SMALL CELL LUNG CANCER RECURRENT |
1 |
0.0035 |
| 72 |
ANDROGENETIC ALOPECIA |
1 |
0.0035 |
| 73 |
DEVICE LOOSENING |
3 |
0.0035 |
| 74 |
PUPIL FIXED |
6 |
0.0035 |
| 75 |
RESTRICTIVE PULMONARY DISEASE |
4 |
0.0034 |
| 76 |
SALIVA ALTERED |
3 |
0.0033 |
| 77 |
BRONCHOSPASM PARADOXICAL |
1 |
0.0033 |
| 78 |
MYXOEDEMA COMA |
1 |
0.0033 |
| 79 |
FOETAL CARDIAC DISORDER |
1 |
0.0032 |
| 80 |
MENINGOCOCCAL INFECTION |
1 |
0.0032 |
| 81 |
HYPERMETROPIA |
3 |
0.0032 |
| 82 |
INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE |
2 |
0.0031 |
| 83 |
ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL |
1 |
0.0031 |
| 84 |
SPUTUM PURULENT |
2 |
0.0030 |
| 85 |
CEREBRAL AMYLOID ANGIOPATHY |
1 |
0.0030 |
| 86 |
GASTROENTERITIS NOROVIRUS |
4 |
0.0030 |
| 87 |
LUNG ADENOCARCINOMA |
9 |
0.0030 |
| 88 |
PRECANCEROUS CONDITION |
2 |
0.0030 |
| 89 |
DRY MOUTH |
241 |
0.0030 |
| 90 |
STOMA SITE REACTION |
2 |
0.0029 |
| 91 |
OCULAR MYASTHENIA |
1 |
0.0029 |
| 92 |
ACCOMMODATION DISORDER |
2 |
0.0027 |
| 93 |
ILEUS PARALYTIC |
12 |
0.0027 |
| 94 |
SERRATIA INFECTION |
2 |
0.0027 |
| 95 |
STOMA SITE INFLAMMATION |
2 |
0.0027 |
| 96 |
URINARY RETENTION |
89 |
0.0027 |
| 97 |
BRONCHOPLEURAL FISTULA |
1 |
0.0027 |
| 98 |
HEAT STROKE |
4 |
0.0026 |
| 99 |
POLYCYSTIC OVARIES |
4 |
0.0026 |
| 100 |
LUNG DIFFUSION TEST DECREASED |
1 |
0.0025 |
| 101 |
EXCESSIVE GRANULATION TISSUE |
2 |
0.0025 |
| 102 |
CLUBBING |
1 |
0.0025 |
| 103 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
2 |
0.0024 |
| 104 |
BRADYCARDIA FOETAL |
2 |
0.0024 |
| 105 |
ABDOMINAL CAVITY DRAINAGE |
1 |
0.0024 |
| 106 |
JOINT SURGERY |
1 |
0.0023 |
| 107 |
DYSCHEZIA |
7 |
0.0023 |
| 108 |
FIBROMA |
2 |
0.0022 |
| 109 |
HERNIA PAIN |
1 |
0.0022 |
| 110 |
ANASTOMOTIC ULCER |
1 |
0.0022 |
| 111 |
MONONEUROPATHY MULTIPLEX |
1 |
0.0022 |
| 112 |
PUPILLARY REFLEX IMPAIRED |
4 |
0.0022 |
| 113 |
EHLERS-DANLOS SYNDROME |
1 |
0.0022 |
| 114 |
BRONCHIAL OBSTRUCTION |
3 |
0.0021 |
| 115 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 116 |
LACRIMATION DECREASED |
1 |
0.0021 |
| 117 |
MOTOR NEURONE DISEASE |
1 |
0.0021 |
| 118 |
SKIN ODOUR ABNORMAL |
8 |
0.0020 |
| 119 |
HYPERTHERMIA MALIGNANT |
3 |
0.0020 |
| 120 |
SMALL CELL LUNG CANCER |
3 |
0.0020 |
| 121 |
LOWER RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0020 |
| 122 |
DRUG LEVEL ABNORMAL |
1 |
0.0019 |
| 123 |
ABNORMAL SENSATION IN EYE |
8 |
0.0019 |
| 124 |
INTERTRIGO |
1 |
0.0018 |
| 125 |
NASAL POLYPS |
9 |
0.0018 |
| 126 |
STOMA SITE DISCHARGE |
5 |
0.0018 |
| 127 |
NAIL DYSTROPHY |
1 |
0.0018 |
| 128 |
BACTERIURIA |
1 |
0.0018 |
| 129 |
MOANING |
2 |
0.0018 |
| 130 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
1 |
0.0017 |
| 131 |
ADENOMYOSIS |
1 |
0.0017 |
| 132 |
BRONCHIECTASIS |
11 |
0.0016 |
| 133 |
PHARYNGEAL HAEMORRHAGE |
2 |
0.0016 |
| 134 |
ELBOW OPERATION |
1 |
0.0016 |
| 135 |
DRUG LEVEL CHANGED |
1 |
0.0016 |
| 136 |
SUBCUTANEOUS HAEMATOMA |
2 |
0.0016 |
| 137 |
CHANGE IN SEIZURE PRESENTATION |
1 |
0.0015 |
| 138 |
CONVERSION DISORDER |
3 |
0.0015 |
| 139 |
HYPOVENTILATION |
5 |
0.0015 |
| 140 |
FORCED VITAL CAPACITY DECREASED |
1 |
0.0015 |
| 141 |
FOAMING AT MOUTH |
3 |
0.0015 |
| 142 |
MICTURITION DISORDER |
5 |
0.0014 |
| 143 |
GLASSY EYES |
1 |
0.0014 |
| 144 |
FORCED EXPIRATORY VOLUME DECREASED |
4 |
0.0014 |
| 145 |
CHYLOTHORAX |
1 |
0.0014 |
| 146 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 147 |
VISION BLURRED |
188 |
0.0014 |
| 148 |
FREEZING PHENOMENON |
5 |
0.0013 |
| 149 |
DECUBITUS ULCER |
11 |
0.0013 |
| 150 |
RHINITIS ALLERGIC |
6 |
0.0013 |
| 151 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 152 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 153 |
PULMONARY FUNCTION TEST ABNORMAL |
2 |
0.0013 |
| 154 |
MYOPERICARDITIS |
1 |
0.0013 |
| 155 |
DRUG TOLERANCE INCREASED |
1 |
0.0013 |
| 156 |
DYSURIA |
47 |
0.0013 |
| 157 |
PLACENTA PRAEVIA |
1 |
0.0013 |
| 158 |
OPHTHALMOPLEGIA |
2 |
0.0013 |
| 159 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 160 |
INHIBITORY DRUG INTERACTION |
2 |
0.0013 |
| 161 |
SARCOIDOSIS |
6 |
0.0013 |
| 162 |
ON AND OFF PHENOMENON |
7 |
0.0013 |
| 163 |
URINE FLOW DECREASED |
3 |
0.0013 |
| 164 |
HAPTOGLOBIN DECREASED |
1 |
0.0012 |
| 165 |
IIIRD NERVE PARALYSIS |
1 |
0.0012 |
| 166 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 167 |
MOUTH SWELLING |
7 |
0.0012 |
| 168 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 169 |
OVARIAN CANCER METASTATIC |
1 |
0.0012 |
| 170 |
INCREASED BRONCHIAL SECRETION |
3 |
0.0012 |
| 171 |
ATONIC SEIZURES |
1 |
0.0012 |
| 172 |
LUNG HYPERINFLATION |
1 |
0.0012 |
| 173 |
THYROIDECTOMY |
2 |
0.0012 |
| 174 |
FOOD REFUSAL |
1 |
0.0011 |
| 175 |
JAUNDICE CHOLESTATIC |
4 |
0.0011 |
| 176 |
ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0011 |
| 177 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
1 |
0.0011 |
| 178 |
COLOUR BLINDNESS |
1 |
0.0011 |
| 179 |
HYPOMANIA |
4 |
0.0011 |
| 180 |
OTOTOXICITY |
2 |
0.0011 |
| 181 |
BIOPSY |
1 |
0.0011 |
| 182 |
OBSTRUCTIVE AIRWAYS DISORDER |
12 |
0.0011 |
| 183 |
INTENTIONAL PRODUCT MISUSE |
94 |
0.0011 |
| 184 |
STOMA SITE ERYTHEMA |
2 |
0.0011 |
| 185 |
ORAL CANDIDIASIS |
14 |
0.0011 |
| 186 |
DELAYED RECOVERY FROM ANAESTHESIA |
1 |
0.0011 |
| 187 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 188 |
ANIMAL SCRATCH |
1 |
0.0010 |
| 189 |
CARDIAC ANEURYSM |
1 |
0.0010 |
| 190 |
DEVICE RELATED SEPSIS |
2 |
0.0010 |
| 191 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 192 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
2 |
0.0010 |
| 193 |
BODY TEMPERATURE FLUCTUATION |
2 |
0.0010 |
| 194 |
PHOTOPHOBIA |
18 |
0.0010 |
| 195 |
COGWHEEL RIGIDITY |
1 |
0.0010 |
| 196 |
PHARYNGEAL ERYTHEMA |
2 |
0.0009 |
| 197 |
ENTERITIS |
6 |
0.0009 |
| 198 |
HYPOMAGNESAEMIA |
13 |
0.0009 |
| 199 |
HIP SURGERY |
5 |
0.0009 |
| 200 |
BLADDER DILATATION |
1 |
0.0009 |
| 201 |
CLAUSTROPHOBIA |
1 |
0.0009 |
| 202 |
CONJUNCTIVITIS |
17 |
0.0009 |
| 203 |
TONGUE DISCOLOURATION |
4 |
0.0009 |
| 204 |
DRY EYE |
45 |
0.0009 |
| 205 |
SALIVARY HYPERSECRETION |
9 |
0.0009 |
| 206 |
TEMPERATURE REGULATION DISORDER |
2 |
0.0009 |
| 207 |
POTENTIATING DRUG INTERACTION |
3 |
0.0009 |
| 208 |
MYOCARDIAL INJURY |
1 |
0.0009 |
| 209 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 210 |
PERIPHERAL EMBOLISM |
1 |
0.0009 |
| 211 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 212 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 213 |
BRONCHIOLITIS |
3 |
0.0009 |
| 214 |
BRONCHIAL HYPERREACTIVITY |
1 |
0.0008 |
| 215 |
APHAGIA |
4 |
0.0008 |
| 216 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 217 |
THROMBOCYTOSIS |
3 |
0.0008 |
| 218 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 219 |
CHRONIC SINUSITIS |
3 |
0.0008 |
| 220 |
NASAL PRURITUS |
1 |
0.0008 |
| 221 |
DYSLIPIDAEMIA |
4 |
0.0008 |
| 222 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 223 |
LIP HAEMORRHAGE |
1 |
0.0008 |
| 224 |
SEROTONIN SYNDROME |
15 |
0.0008 |
| 225 |
VENTRICULAR DYSFUNCTION |
2 |
0.0008 |
| 226 |
ADJUSTMENT DISORDER |
1 |
0.0008 |
| 227 |
LUNG OPACITY |
2 |
0.0008 |
| 228 |
LIP EXFOLIATION |
1 |
0.0008 |
| 229 |
ANION GAP INCREASED |
1 |
0.0007 |
| 230 |
BREAST SWELLING |
2 |
0.0007 |
| 231 |
LARYNGOSPASM |
2 |
0.0007 |
| 232 |
ENURESIS |
3 |
0.0007 |
| 233 |
NEUROMYELITIS OPTICA SPECTRUM DISORDER |
1 |
0.0007 |
| 234 |
RESPIRATORY DEPRESSION |
9 |
0.0007 |
| 235 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 236 |
ECCHYMOSIS |
5 |
0.0007 |
| 237 |
CHOKING SENSATION |
4 |
0.0007 |
| 238 |
GENERALISED TONIC-CLONIC SEIZURE |
12 |
0.0007 |
| 239 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 240 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 241 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 242 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 243 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 244 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 245 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 246 |
CHORIORETINOPATHY |
1 |
0.0007 |
| 247 |
LUNG NEOPLASM |
3 |
0.0007 |
| 248 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 249 |
GENITAL RASH |
1 |
0.0007 |
| 250 |
BLOOD MAGNESIUM DECREASED |
6 |
0.0007 |
| 251 |
FEEDING DISORDER |
14 |
0.0007 |
| 252 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 253 |
STRIDOR |
2 |
0.0007 |
| 254 |
AXILLARY PAIN |
1 |
0.0007 |
| 255 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 256 |
MYOCLONIC EPILEPSY |
1 |
0.0007 |
| 257 |
MOUTH INJURY |
1 |
0.0007 |
| 258 |
MANTLE CELL LYMPHOMA |
1 |
0.0007 |
| 259 |
PALLIATIVE CARE |
1 |
0.0007 |
| 260 |
SPUTUM DISCOLOURED |
6 |
0.0006 |
| 261 |
DISINHIBITION |
1 |
0.0006 |
| 262 |
REBOUND EFFECT |
7 |
0.0006 |
| 263 |
VULVOVAGINAL DRYNESS |
2 |
0.0006 |
| 264 |
THIRST |
11 |
0.0006 |
| 265 |
PITUITARY TUMOUR BENIGN |
1 |
0.0006 |
| 266 |
NEAR DEATH EXPERIENCE |
2 |
0.0006 |
| 267 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 268 |
ERYSIPELAS |
3 |
0.0006 |
| 269 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 270 |
MUSCLE RIGIDITY |
7 |
0.0006 |
| 271 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 272 |
CARDIAC MURMUR |
5 |
0.0006 |
| 273 |
TACHYPHRENIA |
2 |
0.0006 |
| 274 |
PARTIAL SEIZURES |
3 |
0.0006 |
| 275 |
BREAST CYST |
1 |
0.0006 |
| 276 |
ILEUS |
7 |
0.0006 |
| 277 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 278 |
GASTROINTESTINAL MOTILITY DISORDER |
3 |
0.0006 |
| 279 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 280 |
OROPHARYNGEAL PAIN |
51 |
0.0006 |
| 281 |
ASPIRATION |
6 |
0.0005 |
| 282 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 283 |
IMPATIENCE |
1 |
0.0005 |
| 284 |
HYPERTHERMIA |
4 |
0.0005 |
| 285 |
PANCREATIC CYST |
1 |
0.0005 |
| 286 |
MOTION SICKNESS |
1 |
0.0005 |
| 287 |
HYPERVENTILATION |
3 |
0.0005 |
| 288 |
APNOEA |
4 |
0.0005 |
| 289 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 290 |
PHARYNGEAL SWELLING |
5 |
0.0005 |
| 291 |
APPLICATION SITE PAIN |
11 |
0.0005 |
| 292 |
MUCOSAL DRYNESS |
1 |
0.0005 |
| 293 |
TOXIC SKIN ERUPTION |
5 |
0.0005 |
| 294 |
RHINITIS |
4 |
0.0005 |
| 295 |
TENSION |
3 |
0.0005 |
| 296 |
IMMUNE-MEDIATED HEPATITIS |
1 |
0.0005 |
| 297 |
LOWER RESPIRATORY TRACT INFECTION |
22 |
0.0005 |
| 298 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 299 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 300 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 301 |
INCONTINENCE |
5 |
0.0005 |
| 302 |
FULL BLOOD COUNT ABNORMAL |
5 |
0.0005 |
| 303 |
HYPERKINESIA |
1 |
0.0005 |
| 304 |
BRADYCARDIA |
25 |
0.0005 |
| 305 |
METABOLIC ACIDOSIS |
15 |
0.0005 |
| 306 |
CHAPPED LIPS |
2 |
0.0005 |
| 307 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 308 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 309 |
ARTERIOSCLEROSIS CORONARY ARTERY |
3 |
0.0005 |
| 310 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 311 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 312 |
DYSPHAGIA |
42 |
0.0004 |
| 313 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 314 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 315 |
LIP DRY |
4 |
0.0004 |
| 316 |
FLAT AFFECT |
1 |
0.0004 |
| 317 |
NEUROPATHY PERIPHERAL |
41 |
0.0004 |
| 318 |
HAEMOPTYSIS |
12 |
0.0004 |
| 319 |
APHONIA |
6 |
0.0004 |
| 320 |
PERFORMANCE STATUS DECREASED |
2 |
0.0004 |
| 321 |
BLOOD TEST ABNORMAL |
6 |
0.0004 |
| 322 |
APPLICATION SITE REACTION |
3 |
0.0004 |
| 323 |
VENTRICULAR TACHYCARDIA |
7 |
0.0004 |
| 324 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
22 |
0.0004 |
| 325 |
MYOPIA |
1 |
0.0004 |
| 326 |
SLEEP APNOEA SYNDROME |
8 |
0.0004 |
| 327 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 328 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 329 |
CIRCULATORY COLLAPSE |
7 |
0.0004 |
| 330 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 331 |
WHEEZING |
24 |
0.0004 |
| 332 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 333 |
APPLICATION SITE IRRITATION |
5 |
0.0004 |
| 334 |
ANEURYSM |
2 |
0.0004 |
| 335 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 336 |
HYPERHIDROSIS |
51 |
0.0004 |
| 337 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 338 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 339 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 340 |
ACCIDENTAL EXPOSURE TO PRODUCT |
39 |
0.0004 |
| 341 |
SENSORY DISTURBANCE |
6 |
0.0004 |
| 342 |
PRODUCT RESIDUE PRESENT |
2 |
0.0004 |
| 343 |
CLUMSINESS |
1 |
0.0004 |
| 344 |
ABNORMAL FAECES |
3 |
0.0004 |
| 345 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 346 |
CHOKING |
7 |
0.0004 |
| 347 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 348 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
6 |
0.0004 |
| 349 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 350 |
SUBDURAL HAEMATOMA |
5 |
0.0003 |
| 351 |
MYOCARDITIS |
4 |
0.0003 |
| 352 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 353 |
DELIRIUM |
12 |
0.0003 |
| 354 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 355 |
HYPOTHYROIDISM |
11 |
0.0003 |
| 356 |
RALES |
2 |
0.0003 |
| 357 |
EOSINOPHILIA |
6 |
0.0003 |
| 358 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
0.0003 |
| 359 |
NECK INJURY |
1 |
0.0003 |
| 360 |
LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0003 |
| 361 |
BRADYKINESIA |
2 |
0.0003 |
| 362 |
CREPITATIONS |
1 |
0.0003 |
| 363 |
PULMONARY MASS |
5 |
0.0003 |
| 364 |
ODYNOPHAGIA |
2 |
0.0003 |
| 365 |
BLOOD BILIRUBIN INCREASED |
9 |
0.0003 |
| 366 |
MYELOFIBROSIS |
1 |
0.0003 |
| 367 |
CONSTIPATION |
72 |
0.0003 |
| 368 |
EMERGENCY CARE |
1 |
0.0003 |
| 369 |
SCHIZOPHRENIA |
4 |
0.0003 |
| 370 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 371 |
ISCHAEMIC CARDIOMYOPATHY |
1 |
0.0003 |
| 372 |
RECTAL HAEMORRHAGE |
14 |
0.0003 |
| 373 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 374 |
DRY SKIN |
43 |
0.0003 |
| 375 |
MIDDLE INSOMNIA |
6 |
0.0003 |
| 376 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 377 |
BLOOD BLISTER |
1 |
0.0003 |
| 378 |
SECRETION DISCHARGE |
4 |
0.0003 |
| 379 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 380 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 381 |
HYPOCALCAEMIA |
6 |
0.0003 |
| 382 |
DRUG INTERACTION |
50 |
0.0003 |
| 383 |
BLADDER PAIN |
1 |
0.0003 |
| 384 |
PULMONARY FIBROSIS |
6 |
0.0003 |
| 385 |
HYPOXIA |
11 |
0.0003 |
| 386 |
HIATUS HERNIA |
4 |
0.0003 |
| 387 |
BLOOD CREATININE INCREASED |
20 |
0.0003 |
| 388 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 389 |
WALKING AID USER |
2 |
0.0003 |
| 390 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 391 |
EMPHYSEMA |
3 |
0.0003 |
| 392 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0003 |
| 393 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
2 |
0.0003 |
| 394 |
INITIAL INSOMNIA |
3 |
0.0003 |
| 395 |
DYSPNOEA EXERTIONAL |
11 |
0.0003 |
| 396 |
ASTHMA |
33 |
0.0003 |
| 397 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
14 |
0.0003 |
| 398 |
HYPOPNOEA |
1 |
0.0003 |
| 399 |
RHABDOMYOLYSIS |
12 |
0.0003 |
| 400 |
POLLAKIURIA |
12 |
0.0003 |
| 401 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 402 |
AORTIC STENOSIS |
1 |
0.0003 |
| 403 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 404 |
WOUND |
8 |
0.0003 |
| 405 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 406 |
COLD SWEAT |
5 |
0.0003 |
| 407 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 408 |
NEUTROPENIC SEPSIS |
2 |
0.0003 |
| 409 |
LETHARGY |
16 |
0.0003 |
| 410 |
APPARENT DEATH |
1 |
0.0003 |
| 411 |
PULMONARY ARTERIAL HYPERTENSION |
4 |
0.0003 |
| 412 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 413 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
0.0003 |
| 414 |
GASTROINTESTINAL PAIN |
3 |
0.0003 |
| 415 |
PRODUCTIVE COUGH |
13 |
0.0003 |
| 416 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 417 |
IMPULSIVE BEHAVIOUR |
1 |
0.0003 |
| 418 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
54 |
0.0003 |
| 419 |
STATUS EPILEPTICUS |
3 |
0.0003 |
| 420 |
BREAST TENDERNESS |
2 |
0.0003 |
| 421 |
STOMATITIS |
16 |
0.0003 |
| 422 |
WHITE BLOOD CELL COUNT INCREASED |
10 |
0.0003 |
| 423 |
PANIC DISORDER |
1 |
0.0003 |
| 424 |
DYSTONIA |
5 |
0.0003 |
| 425 |
FAECES HARD |
1 |
0.0003 |
| 426 |
SKIN FISSURES |
5 |
0.0003 |
| 427 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 428 |
ELECTROCARDIOGRAM ABNORMAL |
2 |
0.0003 |
| 429 |
RESPIRATORY DISTRESS |
7 |
0.0003 |
| 430 |
PNEUMOTHORAX |
4 |
0.0003 |
| 431 |
MYOCLONUS |
3 |
0.0003 |
| 432 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 433 |
ABSCESS |
4 |
0.0003 |
| 434 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
0.0002 |
| 435 |
MIOSIS |
2 |
0.0002 |
| 436 |
HYPONATRAEMIA |
14 |
0.0002 |
| 437 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 438 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 439 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 440 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0002 |
| 441 |
DYSKINESIA |
10 |
0.0002 |
| 442 |
SPINAL OPERATION |
3 |
0.0002 |
| 443 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 444 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 445 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 446 |
LIVER FUNCTION TEST ABNORMAL |
7 |
0.0002 |
| 447 |
HALLUCINATIONS, MIXED |
1 |
0.0002 |
| 448 |
HAEMATEMESIS |
6 |
0.0002 |
| 449 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 450 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 451 |
BLOOD POTASSIUM DECREASED |
7 |
0.0002 |
| 452 |
ANURIA |
2 |
0.0002 |
| 453 |
FEELING HOT |
14 |
0.0002 |
| 454 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 455 |
PULMONARY CONGESTION |
3 |
0.0002 |
| 456 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 457 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
2 |
0.0002 |
| 458 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 459 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
16 |
0.0002 |
| 460 |
THERAPEUTIC RESPONSE UNEXPECTED |
10 |
0.0002 |
| 461 |
OFF LABEL USE |
195 |
0.0002 |
| 462 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 463 |
DYSPHONIA |
13 |
0.0002 |
| 464 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 465 |
RESTLESS LEGS SYNDROME |
4 |
0.0002 |
| 466 |
PATHOGEN RESISTANCE |
2 |
0.0002 |
| 467 |
LUNG NEOPLASM MALIGNANT |
9 |
0.0002 |
| 468 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 469 |
UROSEPSIS |
2 |
0.0002 |
| 470 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 471 |
PLEURAL EFFUSION |
13 |
0.0002 |
| 472 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 473 |
IMPAIRED QUALITY OF LIFE |
3 |
0.0002 |
| 474 |
LIMB OPERATION |
1 |
0.0002 |
| 475 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 476 |
APATHY |
3 |
0.0002 |
| 477 |
PRESYNCOPE |
5 |
0.0002 |
| 478 |
DYSSTASIA |
6 |
0.0002 |
| 479 |
OEDEMA PERIPHERAL |
25 |
0.0002 |
| 480 |
ASCITES |
6 |
0.0002 |
| 481 |
TACHYCARDIA |
18 |
0.0002 |
| 482 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 483 |
DISABILITY |
4 |
0.0002 |
| 484 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 485 |
AGEUSIA |
5 |
0.0002 |
| 486 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 487 |
ANAPHYLACTIC REACTION |
11 |
0.0002 |
| 488 |
PRODUCT ADMINISTRATION ERROR |
4 |
0.0002 |
| 489 |
HYPOTHERMIA |
2 |
0.0002 |
| 490 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 491 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 492 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 493 |
VISUAL IMPAIRMENT |
24 |
0.0002 |
| 494 |
DELUSION |
3 |
0.0002 |
| 495 |
SWOLLEN TONGUE |
6 |
0.0002 |
| 496 |
RESPIRATORY FAILURE |
14 |
0.0002 |
| 497 |
MALABSORPTION |
1 |
0.0002 |
| 498 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 499 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 500 |
JOINT INJURY |
4 |
0.0002 |
| 501 |
FOOD POISONING |
1 |
0.0002 |
| 502 |
GASTROOESOPHAGEAL REFLUX DISEASE |
15 |
0.0002 |
| 503 |
DYSARTHRIA |
7 |
0.0002 |
| 504 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 505 |
BRUXISM |
1 |
0.0002 |
| 506 |
CHEILITIS |
1 |
0.0002 |
| 507 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 508 |
PULMONARY THROMBOSIS |
2 |
0.0002 |
| 509 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 510 |
PNEUMONIA |
59 |
0.0002 |
| 511 |
ASTHENOPIA |
1 |
0.0002 |
| 512 |
LIP SWELLING |
6 |
0.0002 |
| 513 |
NERVE INJURY |
2 |
0.0002 |
| 514 |
HEPATOTOXICITY |
4 |
0.0002 |
| 515 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 516 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 517 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 518 |
CANDIDA INFECTION |
3 |
0.0002 |
| 519 |
EXPOSURE DURING PREGNANCY |
11 |
0.0002 |
| 520 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
7 |
0.0002 |
| 521 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 522 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 523 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 524 |
HYPERTONIA |
1 |
0.0002 |
| 525 |
CARDIAC FAILURE |
14 |
0.0002 |
| 526 |
EPISTAXIS |
13 |
0.0002 |
| 527 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 528 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 529 |
GENERAL PHYSICAL HEALTH DETERIORATION |
20 |
0.0002 |
| 530 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 531 |
SPINAL PAIN |
2 |
0.0002 |
| 532 |
URINARY TRACT INFECTION |
29 |
0.0002 |
| 533 |
OCULAR HYPERAEMIA |
8 |
0.0002 |
| 534 |
RESPIRATORY DISORDER |
5 |
0.0002 |
| 535 |
INGUINAL HERNIA |
1 |
0.0002 |
| 536 |
RESTLESSNESS |
6 |
0.0002 |
| 537 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 538 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 539 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 540 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 541 |
LEUKOPENIA |
8 |
0.0002 |
| 542 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 543 |
HYPOPHAGIA |
4 |
0.0002 |
| 544 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
7 |
0.0002 |
| 545 |
DIPLOPIA |
4 |
0.0002 |
| 546 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 547 |
NODULE |
2 |
0.0002 |
| 548 |
SKIN IRRITATION |
7 |
0.0002 |
| 549 |
TOOTH INFECTION |
2 |
0.0002 |
| 550 |
HYPOKALAEMIA |
7 |
0.0002 |
| 551 |
ABNORMAL BEHAVIOUR |
6 |
0.0002 |
| 552 |
DISORIENTATION |
6 |
0.0002 |
| 553 |
APPETITE DISORDER |
1 |
0.0002 |
| 554 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 555 |
DEHYDRATION |
20 |
0.0001 |
| 556 |
SYNCOPE |
15 |
0.0001 |
| 557 |
EYE HAEMORRHAGE |
2 |
0.0001 |
| 558 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 559 |
PAIN OF SKIN |
4 |
0.0001 |
| 560 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 561 |
TASTE DISORDER |
3 |
0.0001 |
| 562 |
TACHYPNOEA |
2 |
0.0001 |
| 563 |
MIGRAINE |
14 |
0.0001 |
| 564 |
AKATHISIA |
2 |
0.0001 |
| 565 |
SKIN LESION |
4 |
0.0001 |
| 566 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 567 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 568 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 569 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 570 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 571 |
FORMICATION |
1 |
0.0001 |
| 572 |
DEMENTIA |
4 |
0.0001 |
| 573 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 574 |
DIVERTICULUM |
1 |
0.0001 |
| 575 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 576 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
4 |
0.0001 |
| 577 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 578 |
DEVICE DISLOCATION |
6 |
0.0001 |
| 579 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 580 |
FAECES SOFT |
1 |
0.0001 |
| 581 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 582 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 583 |
CHEST DISCOMFORT |
14 |
0.0001 |
| 584 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 585 |
HEADACHE |
85 |
0.0001 |
| 586 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 587 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 588 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 589 |
PULMONARY OEDEMA |
6 |
0.0001 |
| 590 |
SNEEZING |
3 |
0.0001 |
| 591 |
CORONARY ARTERY DISEASE |
4 |
0.0001 |
| 592 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 593 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 594 |
LYMPHOMA |
2 |
0.0001 |
| 595 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 596 |
COGNITIVE DISORDER |
6 |
0.0001 |
| 597 |
PELVIC FRACTURE |
1 |
0.0001 |
| 598 |
INSOMNIA |
34 |
0.0001 |
| 599 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0001 |
| 600 |
CYANOSIS |
2 |
0.0001 |
| 601 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 602 |
GINGIVAL PAIN |
1 |
0.0001 |
| 603 |
SCIATICA |
2 |
0.0001 |
| 604 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 605 |
CONFUSIONAL STATE |
20 |
0.0001 |
| 606 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 607 |
PRODUCT DOSE OMISSION |
8 |
0.0001 |
| 608 |
ASPHYXIA |
1 |
0.0001 |
| 609 |
CHOLELITHIASIS |
4 |
0.0001 |
| 610 |
DYSPNOEA |
69 |
0.0001 |
| 611 |
HICCUPS |
1 |
0.0001 |
| 612 |
EYE IRRITATION |
7 |
0.0001 |
| 613 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 614 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 615 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 616 |
PALPITATIONS |
14 |
0.0001 |
| 617 |
NASAL CONGESTION |
7 |
0.0001 |
| 618 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 619 |
PERIPHERAL SWELLING |
18 |
0.0001 |
| 620 |
MYOPATHY |
1 |
0.0001 |
| 621 |
HYSTERECTOMY |
1 |
0.0001 |
| 622 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 623 |
ECZEMA |
6 |
0.0001 |
| 624 |
COUGH |
32 |
0.0001 |
| 625 |
GASTRITIS |
3 |
0.0001 |
| 626 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 627 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 628 |
LUNG INFILTRATION |
1 |
0.0001 |
| 629 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 630 |
SEIZURE |
13 |
0.0001 |
| 631 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 632 |
FACIAL PAIN |
1 |
0.0001 |
| 633 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 634 |
MOBILITY DECREASED |
8 |
0.0001 |
| 635 |
OEDEMA |
6 |
0.0001 |
| 636 |
PALLOR |
3 |
0.0001 |
| 637 |
GASTROINTESTINAL CARCINOMA |
1 |
0.0001 |
| 638 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
4 |
0.0001 |
| 639 |
OPTIC NEURITIS |
1 |
0.0001 |
| 640 |
SOMNOLENCE |
22 |
0.0001 |
| 641 |
CARDIAC ARREST |
9 |
0.0001 |
| 642 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 643 |
NERVE COMPRESSION |
1 |
0.0001 |
| 644 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 645 |
CHEST PAIN |
20 |
0.0001 |
| 646 |
FEELING COLD |
3 |
0.0001 |
| 647 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 648 |
PANCYTOPENIA |
6 |
0.0001 |
| 649 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 650 |
APPENDICITIS |
1 |
0.0001 |
| 651 |
FLANK PAIN |
1 |
0.0001 |
| 652 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 653 |
ABDOMINAL DISTENSION |
11 |
0.0001 |
| 654 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 655 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 656 |
ANGINA PECTORIS |
3 |
0.0001 |
| 657 |
HYPOTENSION |
21 |
0.0001 |
| 658 |
INCREASED APPETITE |
2 |
0.0001 |
| 659 |
ACUTE KIDNEY INJURY |
16 |
0.0001 |
| 660 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 661 |
PYREXIA |
36 |
0.0001 |
| 662 |
GLAUCOMA |
2 |
0.0001 |
| 663 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 664 |
ATELECTASIS |
1 |
0.0001 |
| 665 |
ABDOMINAL PAIN |
24 |
0.0001 |
| 666 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 667 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 668 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 669 |
EMBEDDED DEVICE |
1 |
0.0001 |
| 670 |
HEART RATE INCREASED |
10 |
0.0001 |
| 671 |
PRODUCT USE IN UNAPPROVED INDICATION |
25 |
0.0001 |
| 672 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 673 |
EYELID PTOSIS |
1 |
0.0001 |
| 674 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 675 |
EPILEPSY |
3 |
0.0001 |
| 676 |
SKIN BURNING SENSATION |
7 |
0.0001 |
| 677 |
ADVERSE EVENT |
9 |
0.0001 |
| 678 |
MALIGNANT NEOPLASM PROGRESSION |
10 |
0.0001 |
| 679 |
EAR DISCOMFORT |
1 |
0.0001 |
| 680 |
THERAPY CESSATION |
5 |
0.0001 |
| 681 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 682 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 683 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 684 |
FOLLICULITIS |
1 |
0.0001 |
| 685 |
AGITATION |
7 |
0.0001 |
| 686 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 687 |
DECREASED APPETITE |
22 |
0.0001 |
| 688 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 689 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 690 |
DISTURBANCE IN ATTENTION |
5 |
0.0001 |
| 691 |
UNEVALUABLE EVENT |
7 |
0.0001 |
| 692 |
ATRIAL FIBRILLATION |
9 |
0.0001 |
| 693 |
SEPTIC SHOCK |
4 |
0.0001 |
| 694 |
EYE DISORDER |
3 |
0.0001 |
| 695 |
DEPENDENCE |
5 |
0.0001 |
| 696 |
MELAENA |
2 |
0.0001 |
| 697 |
THERAPEUTIC RESPONSE SHORTENED |
3 |
0.0001 |
| 698 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 699 |
EYE PRURITUS |
3 |
0.0001 |
| 700 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 701 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 702 |
FISTULA |
1 |
0.0001 |
| 703 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 704 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 705 |
MICTURITION URGENCY |
1 |
0.0001 |
| 706 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 707 |
HYPERTENSION |
18 |
0.0001 |
| 708 |
ATAXIA |
1 |
0.0001 |
| 709 |
BACTERAEMIA |
1 |
0.0001 |
| 710 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 711 |
COMA |
4 |
0.0001 |
| 712 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 713 |
ELECTROCARDIOGRAM QT PROLONGED |
3 |
0.0001 |
| 714 |
RENAL IMPAIRMENT |
7 |
0.0001 |
| 715 |
PRURITUS |
32 |
0.0001 |
| 716 |
CONTUSION |
8 |
0.0001 |
| 717 |
HYPOGLYCAEMIA |
4 |
0.0001 |
| 718 |
PANIC ATTACK |
3 |
0.0001 |
| 719 |
NEURALGIA |
2 |
0.0001 |
| 720 |
CONDITION AGGRAVATED |
25 |
0.0001 |
| 721 |
CYTOPENIA |
1 |
0.0001 |
| 722 |
LUNG DISORDER |
4 |
0.0001 |
| 723 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 724 |
HYPERSENSITIVITY |
15 |
0.0001 |
| 725 |
EYE SWELLING |
3 |
0.0001 |
| 726 |
PHARYNGITIS |
1 |
0.0001 |
| 727 |
EXTRAPYRAMIDAL DISORDER |
2 |
0.0001 |
| 728 |
MEMORY IMPAIRMENT |
11 |
0.0001 |
| 729 |
INTENTIONAL PRODUCT USE ISSUE |
7 |
0.0001 |
| 730 |
ASTHENIA |
30 |
0.0001 |
| 731 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 732 |
DEPRESSION |
18 |
0.0001 |
| 733 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 734 |
WEIGHT DECREASED |
22 |
0.0001 |
| 735 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 736 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 737 |
ILLNESS |
8 |
0.0001 |
| 738 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 739 |
SKIN ULCER |
2 |
0.0001 |
| 740 |
PARAESTHESIA |
12 |
0.0001 |
| 741 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 742 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 743 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 744 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 745 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 746 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 747 |
PRODUCT USE ISSUE |
14 |
0.0001 |
| 748 |
FEAR |
2 |
0.0001 |
| 749 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 750 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 751 |
LIMB INJURY |
2 |
0.0001 |
| 752 |
BLINDNESS |
3 |
0.0001 |
| 753 |
DRUG INEFFECTIVE |
97 |
0.0001 |
| 754 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 755 |
ERYTHEMA |
15 |
0.0001 |
| 756 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 757 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 758 |
TREMOR |
12 |
0.0001 |
| 759 |
MEDICATION ERROR |
4 |
0.0001 |
| 760 |
HUNGER |
1 |
0.0001 |
| 761 |
SEPSIS |
8 |
0.0001 |
| 762 |
MASS |
1 |
0.0001 |
| 763 |
DIARRHOEA |
46 |
0.0001 |
| 764 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 765 |
EYE PAIN |
4 |
0.0001 |
| 766 |
LYMPHOPENIA |
1 |
0.0001 |
| 767 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 768 |
NASOPHARYNGITIS |
13 |
0.0001 |
| 769 |
DIZZINESS |
35 |
0.0001 |
| 770 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 771 |
BRONCHOSPASM |
1 |
0.0001 |
| 772 |
PARALYSIS |
1 |
0.0001 |
| 773 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 774 |
BALANCE DISORDER |
6 |
0.0001 |
| 775 |
FALL |
23 |
0.0001 |
| 776 |
INFECTION |
10 |
0.0001 |
| 777 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 778 |
RASH |
30 |
0.0001 |
| 779 |
GASTROENTERITIS |
1 |
0.0001 |
| 780 |
SURGERY |
4 |
0.0001 |
| 781 |
NAUSEA |
54 |
0.0001 |
| 782 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 783 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 784 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 785 |
THROAT IRRITATION |
3 |
0.0001 |
| 786 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 787 |
HALLUCINATION |
5 |
0.0001 |
| 788 |
HEPATIC FAILURE |
2 |
0.0001 |
| 789 |
NEUTROPENIA |
9 |
0.0001 |
| 790 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 791 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 792 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 793 |
VERTIGO |
4 |
0.0001 |
| 794 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 795 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 796 |
TINNITUS |
3 |
0.0001 |
| 797 |
OVERDOSE |
14 |
0.0001 |
| 798 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 799 |
ANKLE FRACTURE |
1 |
0.0001 |
| 800 |
LUNG INFECTION |
1 |
0.0001 |
| 801 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 802 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 803 |
BRAIN FOG |
1 |
0.0001 |
| 804 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 805 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 806 |
PULMONARY EMBOLISM |
6 |
0.0001 |
| 807 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 808 |
CYSTITIS |
2 |
0.0001 |
| 809 |
OBESITY |
1 |
0.0001 |
| 810 |
MOOD SWINGS |
2 |
0.0001 |
| 811 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 812 |
HIP FRACTURE |
2 |
0.0001 |
| 813 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 814 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 815 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 816 |
HYPOAESTHESIA |
9 |
0.0001 |
| 817 |
FUNGAL INFECTION |
2 |
0.0001 |
| 818 |
AGGRESSION |
3 |
0.0001 |
| 819 |
GAIT INABILITY |
2 |
0.0001 |
| 820 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 821 |
FACE OEDEMA |
1 |
0.0001 |
| 822 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 823 |
SKIN EXFOLIATION |
5 |
0.0001 |
| 824 |
HEMIPARESIS |
1 |
0.0001 |
| 825 |
FLUSHING |
6 |
0.0001 |
| 826 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 827 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 828 |
FEELING ABNORMAL |
14 |
0.0001 |
| 829 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 830 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 831 |
NEUROTOXICITY |
1 |
0.0001 |
| 832 |
HYPERKALAEMIA |
2 |
0.0001 |
| 833 |
HEART RATE DECREASED |
2 |
0.0001 |
| 834 |
DEPRESSED MOOD |
3 |
0.0001 |
| 835 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 836 |
DRUG ERUPTION |
1 |
0.0001 |
| 837 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
10 |
0.0001 |
| 838 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 839 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 840 |
FATIGUE |
43 |
0.0001 |
| 841 |
URTICARIA |
9 |
0.0001 |
| 842 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 843 |
TOXICITY TO VARIOUS AGENTS |
9 |
0.0001 |
| 844 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 845 |
COLITIS |
2 |
0.0001 |
| 846 |
ANXIETY |
15 |
0.0001 |
| 847 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 848 |
HERPES ZOSTER |
3 |
0.0001 |
| 849 |
CHOLESTASIS |
1 |
0.0001 |
| 850 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 851 |
ERUCTATION |
1 |
0.0001 |
| 852 |
EAR PAIN |
1 |
0.0001 |
| 853 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 854 |
KIDNEY INFECTION |
1 |
0.0001 |
| 855 |
MENORRHAGIA |
1 |
0.0001 |
| 856 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 857 |
DISCOMFORT |
3 |
0.0000 |
| 858 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 859 |
MUSCLE SPASMS |
9 |
0.0000 |
| 860 |
PERITONITIS |
1 |
0.0000 |
| 861 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 862 |
ANAEMIA |
9 |
0.0000 |
| 863 |
EATING DISORDER |
1 |
0.0000 |
| 864 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 865 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 866 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 867 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 868 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 869 |
SWELLING FACE |
3 |
0.0000 |
| 870 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 871 |
MALAISE |
20 |
0.0000 |
| 872 |
HOSPITALISATION |
7 |
0.0000 |
| 873 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 874 |
RENAL FAILURE |
6 |
0.0000 |
| 875 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 876 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 877 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 878 |
VOMITING |
21 |
0.0000 |
| 879 |
ORAL PAIN |
1 |
0.0000 |
| 880 |
DEVICE ISSUE |
4 |
0.0000 |
| 881 |
CHROMATURIA |
1 |
0.0000 |
| 882 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 883 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 884 |
ARTHRALGIA |
18 |
0.0000 |
| 885 |
BURNING SENSATION |
3 |
0.0000 |
| 886 |
SWELLING |
4 |
0.0000 |
| 887 |
CHILLS |
5 |
0.0000 |
| 888 |
SLEEP DISORDER |
3 |
0.0000 |
| 889 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 890 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 891 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 892 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 893 |
FIBROMYALGIA |
1 |
0.0000 |
| 894 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 895 |
COVID-19 |
7 |
0.0000 |
| 896 |
ACNE |
3 |
0.0000 |
| 897 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 898 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 899 |
BACK PAIN |
9 |
0.0000 |
| 900 |
HAEMORRHAGE |
4 |
0.0000 |
| 901 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 902 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 903 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 904 |
MOOD ALTERED |
1 |
0.0000 |
| 905 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 906 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 907 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 908 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 909 |
INFLUENZA |
4 |
0.0000 |
| 910 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 911 |
PAIN IN JAW |
1 |
0.0000 |
| 912 |
HYPERSOMNIA |
1 |
0.0000 |
| 913 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 914 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 915 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 916 |
CATARACT |
2 |
0.0000 |
| 917 |
APHASIA |
1 |
0.0000 |
| 918 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 919 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 920 |
INJECTION SITE RASH |
1 |
0.0000 |
| 921 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 922 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 923 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 924 |
FEMUR FRACTURE |
1 |
0.0000 |
| 925 |
HEAD INJURY |
1 |
0.0000 |
| 926 |
INTENTIONAL OVERDOSE |
2 |
0.0000 |
| 927 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 928 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 929 |
AMNESIA |
2 |
0.0000 |
| 930 |
PAIN IN EXTREMITY |
9 |
0.0000 |
| 931 |
DYSPEPSIA |
3 |
0.0000 |
| 932 |
IMPAIRED HEALING |
1 |
0.0000 |
| 933 |
ANGER |
1 |
0.0000 |
| 934 |
GASTRIC DISORDER |
1 |
0.0000 |
| 935 |
NIGHTMARE |
1 |
0.0000 |
| 936 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 937 |
MYOCARDIAL INFARCTION |
5 |
0.0000 |
| 938 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 939 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 940 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 941 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 942 |
PAIN |
17 |
0.0000 |
| 943 |
CRYING |
1 |
0.0000 |
| 944 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 945 |
INJECTION SITE MASS |
1 |
0.0000 |
| 946 |
BRONCHITIS |
2 |
0.0000 |
| 947 |
DYSGEUSIA |
2 |
0.0000 |
| 948 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 949 |
WEIGHT INCREASED |
6 |
0.0000 |
| 950 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 951 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 952 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 953 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 954 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 955 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 956 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 957 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 958 |
HYPOACUSIS |
1 |
0.0000 |
| 959 |
MENTAL DISORDER |
1 |
0.0000 |
| 960 |
ANGIOEDEMA |
1 |
0.0000 |
| 961 |
LIVER DISORDER |
1 |
0.0000 |
| 962 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 963 |
ARRHYTHMIA |
1 |
0.0000 |
| 964 |
COLORECTAL CANCER |
1 |
0.0000 |
| 965 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 966 |
FLUID RETENTION |
1 |
0.0000 |
| 967 |
SINUSITIS |
2 |
0.0000 |
| 968 |
NERVOUSNESS |
1 |
0.0000 |
| 969 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 970 |
DEATH |
16 |
0.0000 |
| 971 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 972 |
ARTHROPATHY |
1 |
0.0000 |
| 973 |
BLISTER |
1 |
0.0000 |
| 974 |
IRRITABILITY |
1 |
0.0000 |
| 975 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 976 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 977 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 978 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 979 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 980 |
INJURY |
1 |
0.0000 |
| 981 |
HOT FLUSH |
1 |
0.0000 |
| 982 |
ARTHRITIS |
1 |
0.0000 |
| 983 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 984 |
MYALGIA |
2 |
0.0000 |
| 985 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 986 |
CARDIAC DISORDER |
1 |
0.0000 |
| 987 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 988 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 989 |
JOINT SWELLING |
1 |
0.0000 |
| 990 |
DRUG DOSE OMISSION |
1 |
0.0000 |